Cell Bio Human Tech Co.,Ltd (KOSDAQ: 318160)

Cell Bio Human Tech Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,087	4,052	4,495	13,929	6,252	10,871
Short-Term Investments	12,684	9,433	2,400	7,463	6,396	14,000
Trading Asset Securities	-	-	-	-	-	5,030
Cash & Short-Term Investments	16,771	13,485	6,895	21,392	12,649	29,901
Cash Growth	27.70%	95.59%	-67.77%	69.12%	-57.70%	272.61%
Accounts Receivable	3,576	4,241	3,072	3,584	4,623	3,875
Other Receivables	49.72	96.49	32.52	154.82	1,001	451.54
Receivables	3,637	4,337	3,104	3,739	5,624	4,327
Inventory	4,964	8,281	9,106	6,254	4,389	2,735
Prepaid Expenses	188.5	308.51	281.85	55.4	14.22	8.09
Other Current Assets	302.99	506.67	548.41	630.85	730.2	165.27
Total Current Assets	25,863	26,918	19,936	32,071	23,406	37,137
Property, Plant & Equipment	23,051	22,764	23,152	23,904	20,983	8,490
Long-Term Investments	604.68	644.17	548.66	509.54	1,932	2,757
Goodwill	-	-	-	-	220.31	-
Other Intangible Assets	1,264	1,282	818.32	817.77	724.56	721.77
Long-Term Deferred Tax Assets	404.04	557.14	825.57	248.83	27.4	-
Other Long-Term Assets	1,156	1,030	701.66	517.12	602.47	674.57
Total Assets	52,353	53,196	45,982	58,069	47,896	49,780
Accounts Payable	521.4	1,048	861.03	1,953	1,387	650.57
Accrued Expenses	552.7	564.82	709.24	414.39	498.58	442.29
Short-Term Debt	5,815	5,875	4,942	4,735	-	-
Current Portion of Leases	185.99	29.73	220.38	233.33	236.73	402.18
Current Income Taxes Payable	416.73	540.81	573.6	1,449	263.54	144.56
Other Current Liabilities	495.02	499.72	441.35	833.07	799.12	483.52
Total Current Liabilities	7,987	8,559	7,748	9,617	3,185	2,123
Long-Term Debt	-	-	-	9,421	-	-
Long-Term Leases	187.04	21.89	68.78	274.54	459.18	97.14
Long-Term Deferred Tax Liabilities	-	-	-	-	-	17.51
Other Long-Term Liabilities	47.44	53.07	60.34	29.76	39.36	-
Total Liabilities	8,222	8,634	7,877	19,342	3,684	2,238
Common Stock	4,630	4,630	4,100	4,100	4,100	4,100
Additional Paid-In Capital	23,835	23,835	18,077	18,077	18,070	18,070
Retained Earnings	15,082	13,616	21,086	31,294	28,163	23,976
Treasury Stock	-1,856	-37.25	-7,916	-7,916	-7,916	-
Comprensive Income & Other	1,993	2,072	-3,648	-17,136	1,227	856.66
Total Common Equity	43,684	44,116	31,700	28,420	43,644	47,002
Minority Interest	-	-	-	-	121.62	93.43
Shareholders' Equity	44,131	44,563	38,105	38,726	44,213	47,542
Total Liabilities & Equity	52,353	53,196	45,982	58,069	47,896	49,780
Total Debt	6,189	5,927	5,232	14,663	695.91	499.32
Net Cash (Debt)	10,582	7,558	1,663	6,728	11,953	29,402
Net Cash Growth	78.32%	354.47%	-75.28%	-43.71%	-59.35%	266.39%
Net Cash Per Share	1161.12	894.55	237.54	852.31	1484.50	3613.15
Filing Date Shares Outstanding	8.82	9.26	7	7	7.16	8.2
Total Common Shares Outstanding	8.82	9.26	7	7	7.16	8.2
Working Capital	17,876	18,359	12,187	22,454	20,221	35,014
Book Value Per Share	4952.22	4765.58	4527.97	4059.42	6096.97	5731.37
Tangible Book Value	42,420	42,834	30,882	27,602	42,700	46,281
Tangible Book Value Per Share	4808.90	4627.08	4411.09	3942.62	5964.98	5643.36
Land	-	2,360	2,360	2,360	2,360	2,329
Buildings	-	8,442	8,459	8,282	422.5	349.3
Machinery	-	10,287	10,742	10,622	5,304	4,329
Construction In Progress	-	128.07	30.27	310.99	11,915	71.5

Source: S&P Capital IQ. Standard template. Financial Sources.